Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion

Clinical trial NCT00150085 · TERMINATED

Trial details

NCT number: NCT00150085
Sponsor: Novartis
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Tacrolimus-associated Abnormal Glucose Metabolism in Kidney and Liver Transplant Recipients

Start date: 2004-02-01
Primary completion: 2005-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.